Pro Share Advisors LLC Nkarta, Inc. Transaction History

Pro Share Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 08, 2022	SELL	$12.79 - $26.88 $113,038 - $237,565	-8,838 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$26.67 - $38.76 $19,175 - $27,868	-719 Reduced 7.52%	8,838 $246,000
Q2 2021 Aug 13, 2021	SELL	$23.94 - $36.68 $9,432 - $14,451	-394 Reduced 3.96%	9,557 $303,000
Q1 2021 May 14, 2021	BUY	$31.33 - $59.61 $41,386 - $78,744	1,321 Added 15.31%	9,951 $327,000
Q4 2020 Feb 09, 2021	BUY	$27.03 - $75.62 $233,268 - $652,600	8,630 New	8,630 $530,000

129

66.5M

173K

20K

Ticker NKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,656,800
Market Cap $145M
Description
Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Pro Share Advisors LLC with notifications on news.